Elanco Director Purchases 40,000 Shares for $936,000
Purchasing 40,000 shares is a bullish signal for shareholders.
Overview
Lawrence Erik Kurzius, Director at Elanco Animal Health(NYSE:ELAN), purchased 40,000 shares of common stock at $23.40 per share on Aug. 20, 2026, according to a recent SEC Form 4 filing.
Transaction value based on SEC Form 4 weighted average purchase price ($23.40); post-transaction value based on Aug. 20, 2026, market close ($23.56).
Details
Elanco Animal Health is a leading global animal health company with approximately 9,400 employees and TTM revenues of $5 billion, demonstrating substantial scale in the specialized pharmaceutical and animal health sector. The company maintains a diversified business model spanning companion animal preventative care, therapeutic treatments, and livestock health solutions, enabling revenue generation across multiple customer segments and geographies. Elanco's competitive positioning is strengthened by its portfolio of established brands and comprehensive product offerings that address critical animal health needs in both companion and production animal markets.
Source
Originally published at www.fool.com.